Quidel | QDEL - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Agilent USD 364M 78M 2025-12
Avanos Medical USD 1.2M 2.4M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bruker USD 68.2M 140.8M 2025-12
Cerus USD -20.76M 17.9M 2024-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Danaher USD 1.24B 138M 2026-03
Haemonetics USD 59.97M 8.69M 2025-12
Illumina USD 157M 220M 2026-03
IQVIA Holdings USD 6.22B 5.68B 2026-03
Merit Medical Systems USD 51.06M 22.12M 2025-12
Mettler Toledo International USD 329.07M 59.84M 2025-12
Myriad Genetics USD 4.6M 3.4M 2025-12
Neogen USD 28M 15.81M 2025-09
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Quidel USD -79.5M 32.9M 2026-03
Revvity USD 91.56M 35.88M 2025-12
STAAR Surgical USD -20.65M 39.44M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Waters USD 264.18M 94.06M 2025-12